ES2167906T3 - Nuevo procedimiento de analisis de los receptores plaquetarios gpiib/iiia. - Google Patents

Nuevo procedimiento de analisis de los receptores plaquetarios gpiib/iiia.

Info

Publication number
ES2167906T3
ES2167906T3 ES98929487T ES98929487T ES2167906T3 ES 2167906 T3 ES2167906 T3 ES 2167906T3 ES 98929487 T ES98929487 T ES 98929487T ES 98929487 T ES98929487 T ES 98929487T ES 2167906 T3 ES2167906 T3 ES 2167906T3
Authority
ES
Spain
Prior art keywords
receptors
gpiib
iiia
plaquetary
analysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98929487T
Other languages
English (en)
Inventor
Isabelle Besson-Faure
Michel Canton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocytex SRL
Original Assignee
Biocytex SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocytex SRL filed Critical Biocytex SRL
Application granted granted Critical
Publication of ES2167906T3 publication Critical patent/ES2167906T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/75—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO DE DOSIFICACION, EN UNA MUESTRA QUE HAY QUE PROBAR, DE LA OCUPACION DEL RECEPTOR CELULAR GPIIB/IIIA POR UN ANTAGONISTA DEL FIBRINOGENO, CARACTERIZADO PORQUE SE DOSIFICA EN DICHA MUESTRA EL NUMERO DE RECEPTORES OCUPADOS MEDIANTE UN ANTICUERPO COMPETIDOR MAB1 DEL ANTAGONISTA ASI COMO EL NUMERO DE RECEPTORES TOTALES OCUPADOS O NO MEDIANTE UN ANTICUERPO ESPECIFICO DEL RECEPTOR OCUPADO O NO, MAB2 LLAMADO NO COMPETIDOR, DE DONDE DE DEDUCE EL NIVEL DE OCUPACION DE LOS RECEPTORES GPIIB/IIIA EN LA MUESTRA.
ES98929487T 1997-06-06 1998-06-04 Nuevo procedimiento de analisis de los receptores plaquetarios gpiib/iiia. Expired - Lifetime ES2167906T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707059A FR2764388B1 (fr) 1997-06-06 1997-06-06 Nouvelle methode d'analyse des recepteurs plaquettaires gpiib/iiia

Publications (1)

Publication Number Publication Date
ES2167906T3 true ES2167906T3 (es) 2002-05-16

Family

ID=9507713

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98929487T Expired - Lifetime ES2167906T3 (es) 1997-06-06 1998-06-04 Nuevo procedimiento de analisis de los receptores plaquetarios gpiib/iiia.

Country Status (10)

Country Link
US (1) US6168925B1 (es)
EP (1) EP0920628B1 (es)
JP (1) JP3713716B2 (es)
AT (1) ATE210297T1 (es)
DE (1) DE69802775T2 (es)
DK (1) DK0920628T3 (es)
ES (1) ES2167906T3 (es)
FR (1) FR2764388B1 (es)
HK (1) HK1021225A1 (es)
WO (1) WO1998055868A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2829500B1 (fr) * 2001-09-13 2003-12-12 Hemosystem Procede de concentration et de detection de germes pathogenes a partir de produits sanguins et/ou de leurs derives et dispositif pour le mettre en oeuvre
FR2901281B1 (fr) * 2006-05-19 2008-08-15 Hemosystem Sa Procede d'extraction des acides desoxyribonucleiques (adn)de microorganismes eventuellement presents dans un echantillon sanguin
AU2009273540A1 (en) * 2008-07-25 2010-01-28 Merck Patent Gmbh Method of determination of receptor binding saturation effected by monoclonal antibodies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918004A (en) * 1984-12-24 1990-04-17 Caribbean Microparticles Corporation Method of calibrating a flow cytometer or fluorescence microscope for quantitating binding antibodies on a selected sample, and microbead calibration kit therefor
US5387413A (en) * 1985-06-14 1995-02-07 The Research Foundation Of State University Of New York Method of inhibiting thrombus formation by the 7E3 monoclonal antibody
US5114842A (en) * 1987-07-08 1992-05-19 The Scripps Research Institute Peptides and antibodies that inhibit platelet adhesion
US5196309A (en) * 1990-11-15 1993-03-23 The Scripps Research Institute Characterization of platelet aggregation disorders
US5427913A (en) * 1992-12-03 1995-06-27 Alberta Cancer Board Methods for determining platelet function
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay

Also Published As

Publication number Publication date
WO1998055868A1 (fr) 1998-12-10
DE69802775T2 (de) 2002-08-08
EP0920628A1 (fr) 1999-06-09
US6168925B1 (en) 2001-01-02
DE69802775D1 (de) 2002-01-17
FR2764388A1 (fr) 1998-12-11
JP3713716B2 (ja) 2005-11-09
ATE210297T1 (de) 2001-12-15
DK0920628T3 (da) 2002-02-25
JP2000517060A (ja) 2000-12-19
HK1021225A1 (en) 2000-06-02
FR2764388B1 (fr) 1999-08-27
EP0920628B1 (fr) 2001-12-05

Similar Documents

Publication Publication Date Title
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
DK1316801T3 (da) Sammensætninger og fremgangsmåder til detektion og behandling af sygdomme og tilstande, som er relateret til kemokinreceptorer
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
WO2002010956A3 (en) Computer method and apparatus for determining site type of a web site
DE69940958D1 (de) Bestimmungsmethode fur liganden der nuklearen rezeptoren
ES2042550T3 (es) Metodos para proporcionar referencias internas para uso en ensayos de analito-receptor.
ATE295376T1 (de) Monoklonaler antikörper als hemmstoff für gm-csf, il-3, il-5 und andere zytokine und deren verwendung
ES2103136T3 (es) Kit de ensayo.
ES2057571T3 (es) Receptor de pdgf-alfa.
PT807124E (pt) Anticorpo monoclonal contra o receptor tirosina-quinase flt4 e sua utilizacao em diagnostico e terapeutica
DE69718261D1 (de) Für staphylococcus aureus spezifischer antikörper und seine verwendung
DK0482176T3 (da) Monoklonale antistoffer, der er specifikke for Toxin B Fra Clostridium difficile
ATE308609T1 (de) Pth rezeptor und testverfahren unter verwendung desselben
DE69837811D1 (de) Menschlicher lysophosphatidsäure rezeptor und dessen verwendung
DK0460190T3 (da) Fremgangsmåde til påvisning af maligne sygdomme
ES2167906T3 (es) Nuevo procedimiento de analisis de los receptores plaquetarios gpiib/iiia.
WO2003019136A3 (en) Methods for inhibiting angiogenesis
DK0979410T3 (da) Fremgangsmåde til bestemmelse af cytokinreceptoraktivering ved anvendelse af et antistof
ATE457317T1 (de) Chemokine rezeptor
ATE266870T1 (de) Verfahren zur erfassung oder quantifizierung von basophilen und eosinophilen
ATE156862T1 (de) In vitro verfahren zur bewertung von effekten einer substanz
WO2003001203A3 (en) Inverse chromatography methods and apparatus for evaluation of interactions between modifying agents and receptors
BR1100559B1 (pt) mÉtodo de sondagem para identificar anticorpos especÍficos para antÍgenos selecionados.
Pluta A mixture proportioning method for fly ash concrete utilizing a strength definition for the water to cementitious ratio
ATE289070T1 (de) Nachweisverfahren für microthrix parvicella